Deep soft tissue infections;Infections profondes des tissus mous

Revue Medicale Suisse

Volumn 10, Issue 427, 2014, Pages 920-924

  Chargui, M ^a   Uckay I ^a   Suva D ^a   Christofilopoulos, P ^a   Lomessy, A ^a   Pittet, D ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; CLINICAL FEATURE; DETERIORATION; ERYSIPELAS; HEALTH STATUS; HUMAN; MULTICENTER STUDY (TOPIC); PATHOPHYSIOLOGY; SHORT SURVEY; SKIN INFECTION; SOFT TISSUE INFECTION;

ANTI-BACTERIAL AGENTS; DEBRIDEMENT; HUMANS; HYPERBARIC OXYGENATION; SOFT TISSUE INFECTIONS;

EID: 84900565937     PISSN: 16609379     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (15)

1. ** Blum CL, Menzinger S, Genné D. Erysipèle: manifestations cliniques et prise en charge. Rev Med Suisse 2013;9:1812-5.
2. Darbellay P, Uçkay I, Dominguez D, et al. Traitement du pied diabétique infecté: une approche multidisciplinaire par excellence. Rev Med Suisse 2011;7:894-7.
3. Tognetti L, Martinelli C, Berti S, et al. Bacterial skin and soft tissue infections: Review of the epidemiology, microbiology, aetiopathogenesis and treatment: A collaboration between dermatologists and infectiologists. J Eur Acad Dermatol Venereol 2012;26:931-41.
4. Uçkay I, Sax H, Harbarth S, et al. Multi-resistant infections in repatriated patients after natural disasters: Lessons learned from the 2004 tsunami for hospital infection control. J Hosp Infect 2008;68:1-8.
5. Reber A, Moldovan A, Dunkel N, et al. Should the methicillin-resistant Staphylococcus aureus carriage status be used as a guide to treatment for skin and soft tissue infections ? J Infect 2012;64:513-9.
6. Uçkay I, Ferry T, Stern R, et al. Use of serum anti-streptolysin-O-titers in the microbial diagnosis of orthopedic infections. Int J Inf Dis 2009;13:421-4.
7. Kim KT, KimYJ, Lee JW, et al. Can necrotizing infectious fasciitis be differentiated from nonnecrotizing infectious fasciitis with MR imaging ? Radiology 2011;259:816-21.
8. * Stamenkovic I, Lew PD. Early recognition of potentially fatal necrotising fasciitis: Use of frozen-section biopsy. N Engl J Med 1984;310:1689-93. (Pubitemid 14083438)
9. Sarani B, Strong M, Pascual J. Necrotizing fasciitis: Current concepts and review of the literature. J Am Coll Surg 2008;208;279-88.
10. Anaya DA, McMahon K, Nathens AB, et al. Predictors of mortality and limb loss in necrotizing soft tissue infections. Arch Surg 2005;140:151-6.
11. * Kaul R, McGeer A, Norrby-Teglund A, et al. Intravenous therapy for streptococcal toxic shock syndrome - A comparative observational study. Clin Infect Dis 1999;28:800-7.
12. Baxter CR. Surgical management of soft tissue infections. Surg Clin North Am 1972;52:1483-99.
13. Öztürk E, Özgüç H, Yilmazlar T. The use of vacuum-assisted closure therapy in the management of Fournier's gangrene. Am J Surg 2009;197:660-5.
14. ** Darenberg J, Ihendyane N, Sjölin J, et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: A European randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2003;37:333-40. (Pubitemid 36976489)
15. Weaver LK. Hyperbaric oxygen in the critically ill. Crit Care Med 2011;39:1784-91.